Drug
Etodolac clinical trials
Keep track of what changes. Save the Etodolac studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2012 | 2 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 8
IPCA Laboratories Ltd. (2) · Assaf-Harofeh Medical Center (2) · Yuzuncu Yıl University (1) · MEDRx USA, Inc. (1) · Flavia Pardo Salata Nahsan (1) · Memorial Sloan Kettering Cancer Center (1) · Konya Beyhekim Training and Research Hospital (1) · Kaplan Medical Center (1)
Often tested with
Tested in the same studies.
Propranolol (5) · Thiocolchicoside (1) · Lidocaine (1) · Meloxicam (1)
Studies
Open first, then newest update. How each study uses Etodolac is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)RecruitingNot applicableMemorial Sloan Kettering Cancer CenterNCT05429970Written as Etodolac
- Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive CapsulitisRecruitingNot applicableKonya Beyhekim Training and Research HospitalNCT07493226Written as acetic acid derivatives
- Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative SurgeryRecruitingPhase 2Assaf-Harofeh Medical CenterNCT03838029Written as Propranolol and etodolac
- Colorectal Metastasis Prevention International Trial 2RecruitingPhase 2Assaf-Harofeh Medical CenterNCT03919461Written as Propranolol and etodolac
- Evaluation of the Effects of Treatments Applied to Patients With Facial Myalgia on Occlusion ParametersCompletedNot applicableYuzuncu Yıl UniversityNCT05261971Written as Etodolac 400 MG
- MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle SprainsCompletedPhase 3MEDRx USA, Inc.NCT01198834Written as Etodolac
- Etodolac and Post-bleaching SensitivityCompletedPhase 4Flavia Pardo Salata NahsanNCT02881619Written as Etodolac
- Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer SurgeryStatus unknownNot applicableKaplan Medical CenterNCT00502684Written as Propranolol, etodolac
- Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed ConditionCompletedPhase 1IPCA Laboratories Ltd.NCT01831687Written as Etodolac Extended Release Tablets 600mg
- Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting ConditionCompletedPhase 1IPCA Laboratories Ltd.NCT01827865Written as Etodolac Extended Release Tablets 600mg
- β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer RecurrenceStatus unknownPhase 3Sheba Medical CenterNCT00888797Written as Propranolol and Etodolac
As the comparator · 4 — what is tested is compared with Etodolac
- Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar ExtractionTerminatedPhase 3Apsen Farmaceutica S.A.NCT03127592Written as Etodolac
- A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain PatientsCompletedPhase 3Astellas Pharma IncNCT01118572Written as etodolac
- Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed ConditionCompletedPhase 1IPCA Laboratories Ltd.NCT01749228Written as Etodolac
- Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting ConditionCompletedPhase 1IPCA Laboratories Ltd.NCT01746719Written as Etodolac
Codes
What other systems call Etodolac · ClinicalTrials.gg INT008578
- MeSH (NLM) D017308EtodolacConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2M36281008ETODOLACConfirmed FDA, NLM, Wikidata
- RxNorm 24605Confirmed FDA, Wikidata
- Wikidata Q2465218(RS)-etodolacConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47526EtodolacOne source FDA
- DrugBank DB00749One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017308 | Etodolac | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2M36281008 | ETODOLAC | Confirmed FDA, NLM, Wikidata |
| RxNorm | 24605 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2465218 | (RS)-etodolac | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47526 | Etodolac | One source FDA |
| DrugBank | DB00749 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.